[{"address1": "11085 Torreyana Road", "city": "San Diego", "state": "CA", "zip": "92121", "country": "United States", "phone": "858 558 0708", "fax": "858 558 0709", "website": "https://www.bioatla.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "BioAtla, Inc., a clinical-stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. The company's lead clinical stage product candidates include mecbotamab vedotin (BA3011), a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for treating undifferentiated pleomorphic sarcoma and non-small cell lung cancer (NSCLC); and ozuriftabmab vedotin (BA3021), a CAB ADC to treat melanoma and squamous cell carcinoma of head and neck. It is also developing Evalstotug (BA3071), a CAB anti-cytotoxic T-lymphocyte-associated antigen 4 antibody for treating melanoma, renal cell carcinoma, colorectal cancer, and NSCLC; BA3182, a bispecific candidate to treat adenocarcinomas; BA3361, a CAB-Nectin-4-ADC for treating tumors; BA3142, a dual-CAB T-cell engager targeting B7-H3, a protein expressed on various solid tumors; and preclinical candidate for CAB-Nectin 4 x CAB-CD3. The company was founded in 2007 and is headquartered in San Diego, California.", "fullTimeEmployees": 61, "companyOfficers": [{"maxAge": 1, "name": "Dr. Jay M. Short Ph.D.", "age": 66, "title": "Co-Founder, CEO & Chairman", "yearBorn": 1958, "fiscalYear": 2024, "totalPay": 1010378, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Richard A. Waldron", "age": 70, "title": "Senior VP & CFO", "yearBorn": 1954, "fiscalYear": 2024, "totalPay": 600800, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Eric L. Sievers M.D.", "age": 60, "title": "Chief Medical Officer", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 637775, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christian J. Vasquez CPA", "age": 48, "title": "Chief Accounting Officer, Controller and Corporate Secretary", "yearBorn": 1976, "fiscalYear": 2024, "totalPay": 408745, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Susie  Melody", "title": "Senior Vice President of Human Resources", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Cathy  Chang Ph.D.", "title": "Senior Vice President of Research & Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Gerhard  Frey Ph.D.", "title": "Senior Vice President of Technology Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Monica  Sullivan", "title": "Senior Vice President of Intellectual Property & Contracts", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sheri  Lydick", "title": "Chief Commercial Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Lisa M. Pelton", "title": "Accounting Manager", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 4, "boardRisk": 8, "compensationRisk": 7, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1759276800, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.7363, "open": 0.7329, "dayLow": 0.7, "dayHigh": 0.8548, "regularMarketPreviousClose": 0.7363, "regularMarketOpen": 0.7329, "regularMarketDayLow": 0.7, "regularMarketDayHigh": 0.8548, "payoutRatio": 0.0, "beta": 1.024, "forwardPE": -0.5644218, "volume": 1178868, "regularMarketVolume": 1178868, "averageVolume": 944350, "averageVolume10days": 1718720, "averageDailyVolume10Day": 1718720, "bid": 0.8058, "ask": 0.8393, "bidSize": 16, "askSize": 16, "marketCap": 48721300, "fiftyTwoWeekLow": 0.24, "fiftyTwoWeekHigh": 2.525, "allTimeHigh": 76.63, "allTimeLow": 0.24, "priceToSalesTrailing12Months": 4.429209, "fiftyDayAverage": 0.60224, "twoHundredDayAverage": 0.457565, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 36559300, "profitMargins": 0.0, "floatShares": 46161628, "sharesOutstanding": 58721588, "sharesShort": 4282858, "sharesShortPriorMonth": 3978046, "sharesShortPreviousMonthDate": 1756425600, "dateShortInterest": 1759190400, "sharesPercentSharesOut": 0.0729, "heldPercentInsiders": 0.10583, "heldPercentInstitutions": 0.28616, "shortRatio": 4.26, "shortPercentOfFloat": 0.08180001, "impliedSharesOutstanding": 58721589, "bookValue": -0.285, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -59515000, "trailingEps": -1.1, "forwardEps": -1.47, "enterpriseToRevenue": 3.324, "enterpriseToEbitda": -0.585, "52WeekChange": -0.57435894, "SandP52WeekChange": 0.13837254, "quoteType": "EQUITY", "currentPrice": 0.8297, "targetHighPrice": 10.0, "targetLowPrice": 10.0, "targetMeanPrice": 10.0, "targetMedianPrice": 10.0, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 18207000, "totalCashPerShare": 0.31, "ebitda": -62465000, "totalDebt": 6045000, "quickRatio": 1.097, "currentRatio": 1.242, "totalRevenue": 11000000, "revenuePerShare": 0.205, "returnOnAssets": -0.82517, "returnOnEquity": -8.1388, "grossProfits": -51194000, "freeCashflow": -29190876, "operatingCashflow": -52323000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -5.74718, "financialCurrency": "USD", "symbol": "BCAB", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "BioAtla, Inc.", "longName": "BioAtla, Inc.", "corporateActions": [], "postMarketTime": 1760742483, "regularMarketTime": 1760731201, "exchange": "NCM", "messageBoardId": "finmb_105291463", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "twoHundredDayAverageChange": 0.37213498, "twoHundredDayAverageChangePercent": 0.81329423, "priceToBook": -2.9112282, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-12-16", "cryptoTradeable": false, "marketState": "CLOSED", "regularMarketChangePercent": 12.685, "regularMarketPrice": 0.8297, "fiftyTwoWeekHighChangePercent": -0.671406, "fiftyTwoWeekChangePercent": -57.435894, "earningsTimestamp": 1754596800, "earningsTimestampStart": 1762459200, "earningsTimestampEnd": 1762459200, "earningsCallTimestampStart": 1754598600, "earningsCallTimestampEnd": 1754598600, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -1.1, "epsForward": -1.47, "epsCurrentYear": -1.19333, "priceEpsCurrentYear": -0.6952812, "fiftyDayAverageChange": 0.22745997, "fiftyDayAverageChangePercent": 0.3776899, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1608129000000, "postMarketChangePercent": 1.2293628, "postMarketPrice": 0.8399, "postMarketChange": 0.010200024, "regularMarketChange": 0.0934, "regularMarketDayRange": "0.7 - 0.8548", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 944350, "fiftyTwoWeekLowChange": 0.5897, "fiftyTwoWeekLowChangePercent": 2.4570832, "fiftyTwoWeekRange": "0.24 - 2.525", "fiftyTwoWeekHighChange": -1.6953001, "displayName": "BioAtla", "trailingPegRatio": null, "__fetch_time": "2025-10-18"}]